Determinants of Tenascin-C and HIV-1 envelope binding and neutralization.
Journal Article (Journal Article)
Interactions between innate antiviral factors at mucosal surfaces and HIV-1 virions contribute to the natural inefficiency of HIV-1 transmission and are a platform to inform the development of vaccine and nonvaccine strategies to block mucosal HIV-1 transmission. Tenascin-C (TNC) is a large, hexameric extracellular matrix glycoprotein identified in breast milk and genital fluids that broadly neutralizes HIV-1 via interaction with the HIV-1 Envelope (Env) variable 3 (V3) loop. In this report, we characterize the specific determinants of the interaction between TNC and the HIV-1 Env. We observed that TNC binding and neutralization of HIV-1 is dependent on the TNC fibrinogen-like globe (fbg) and fibronectin-type III (fn) domains, oligomerization, and its newly-mapped glycan structure. Moreover, we observed that TNC-mediated neutralization is also dependent on Env V3 residues 321/322 and 326/327, which surround the IGDIR motif of the V3 loop, as well the N332 glycan, which is critical to the broadly neutralizing activity of glycan-dependent V3-specific antibodies such as PGT128. Our results demonstrate a striking parallel between innate and adaptive immune mechanisms of broad HIV neutralization and provide further insight into the host protein-virus interactions responsible for the natural inefficiency of mucosal HIV-1 transmission.
Full Text
Duke Authors
Cited Authors
- Mangan, RJ; Stamper, L; Ohashi, T; Eudailey, JA; Go, EP; Jaeger, FH; Itell, HL; Watts, BE; Fouda, GG; Erickson, HP; Alam, SM; Desaire, H; Permar, SR
Published Date
- July 2019
Published In
Volume / Issue
- 12 / 4
Start / End Page
- 1004 - 1012
PubMed ID
- 30976088
Pubmed Central ID
- PMC6599478
Electronic International Standard Serial Number (EISSN)
- 1935-3456
Digital Object Identifier (DOI)
- 10.1038/s41385-019-0164-2
Language
- eng
Conference Location
- United States